Kypha’s mission is to enable and deliver precise, real-time information from complement, the most inaccessible element of the innate immune system. By doing so we aim to put within reach earlier, more-informed clinical research and therapeutic decisions and better outcomes for every patient with an immune-related condition. At Kypha, our technology allows us to gain real-time insight into complement proteins – as well as cytokines, chemokines and other biologically labile immune signals. We have developed a point-of-care platform designed for measurement of either single analyte (CompAct®) or multiplex (RapiPlex) samples. By enabling measurement of these samples within minutes, we can assess an individual’s immune status with a far higher degree of accuracy and reproducibility. And because it is embedded into our detection technology, this information can be readily available at the point of care. By being able to measure specific elements of the complement cascade quickly and reliably, we can open to door to deeper understanding of the role of complement and pave the way for the next generation of therapies.